1-[7-(2-methoxyphenyl)-1H-indazol-5-yl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one
C26H26N6O3S — CID 122654107
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[7-(2-methoxyphenyl)-1H-indazol-5-yl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one
1-[7-(2-methoxyphenyl)-1H-indazol-5-yl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one (PubChem CID 122654107) has the molecular formula C26H26N6O3S and a molecular weight of 502.60 g/mol. Its IUPAC name is 1-[7-(2-methoxyphenyl)-1H-indazol-5-yl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one.
Molecular Properties
| Compound Name | 1-[7-(2-methoxyphenyl)-1H-indazol-5-yl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one |
|---|---|
| PubChem CID | 122654107 |
| Molecular Formula | C26H26N6O3S |
| Molecular Weight | 502.60 g/mol |
| Exact Mass | 502.18 |
| IUPAC Name | 1-[7-(2-methoxyphenyl)-1H-indazol-5-yl]-4-[4-(1,3-thiazole-2-carbonyl)piperazin-1-yl]pyrrolidin-2-one |
| SMILES | COc1ccccc1-c1cc(N2CC(N3CCN(C(=O)c4nccs4)CC3)CC2=O)cc2cn[nH]c12 |
| InChI | InChI=1S/C26H26N6O3S/c1-35-22-5-3-2-4-20(22)21-13-18(12-17-15-28-29-24(17)21)32-16-19(14-23(32)33)30-7-9-31(10-8-30)26(34)25-27-6-11-36-25/h2-6,11-13,15,19H,7-10,14,16H2,1H3,(H,28,29) |
| InChIKey | HNVGVIZKAOTIFG-UHFFFAOYSA-N |
| XLogP | 3.26 |
| TPSA | 94.66 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.60 |
| LogP ≤ 5 | 3.26 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122654107 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.